Authorization Request Form and Certification /Letter of Medical Necessity for Compounded Drugs (OWCP-26)

OWCP will require the claimant’s treating physician to complete a Form OWCP-26 online before payment will be made for a compounded drug. The physician will be required to specify the ingredients in the compounded drug, indicate whether the compounded drug and each of its ingredients are medically necessary, and explain why the claimant cannot use an FDA-approved drug instead of the compounded drug being prescribed. The form will permit the OWCP to more easily track the volume, type, and characteristics of compounded drugs prescribed for claimants. It will allow additional oversight of the pharmacy benefit—improving patient safety, decreasing cost for stakeholders, and decreasing the risk for fraud, waste, and abuse. Completed forms will be reviewed by a clinical pharmacist or physician before being reviewed for decision by the individual program staff.

The latest form for Authorization Request Form and Certification /Letter of Medical Necessity for Compounded Drugs (OWCP-26) expires 2027-07-31 and can be found here.